These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29134797)

  • 1. The Importance of Collaboration between Industry, Academics, and Nonprofits in Tropical Disease Drug Discovery.
    Ferrins L; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):445-448. PubMed ID: 29134797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative development of antimicrobials: looking back to look ahead.
    Nathan C
    Nat Rev Microbiol; 2015 Oct; 13(10):651-7. PubMed ID: 26373373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery and development for neglected diseases: the DNDi model.
    Chatelain E; Ioset JR
    Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informatics for neglected diseases collaborations.
    Bost F; Jacobs RT; Kowalczyk P
    Curr Opin Drug Discov Devel; 2010 May; 13(3):286-96. PubMed ID: 20443162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM; Rohrbaugh ML
    Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public-Private Partnerships in Lead Discovery: Overview and Case Studies.
    Gottwald M; Becker A; Bahr I; Mueller-Fahrnow A
    Arch Pharm (Weinheim); 2016 Sep; 349(9):692-7. PubMed ID: 27335205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precarious connections: making therapeutic production happen for malaria and tuberculosis.
    Craddock S
    Soc Sci Med; 2015 Mar; 129():36-43. PubMed ID: 25142906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development.
    Davis AM; Engkvist O; Fairclough RJ; Feierberg I; Freeman A; Iyer P
    SLAS Discov; 2021 Jun; 26(5):604-619. PubMed ID: 33586501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of NTDs Drug-discovery Research Consortium].
    Namatame I
    Yakugaku Zasshi; 2016; 136(2):231-6. PubMed ID: 26831798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making space for anti-infective drug discovery.
    Nathan C
    Cell Host Microbe; 2011 May; 9(5):343-8. PubMed ID: 21575903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special Issue on Drug Discovery for Global Health.
    ACS Infect Dis; 2018 Apr; 4(4):429-430. PubMed ID: 29649879
    [No Abstract]   [Full Text] [Related]  

  • 16. Interview with Solomon Nwaka.
    Nwaka S
    Future Med Chem; 2011 Sep; 3(11):1339-44. PubMed ID: 21879840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R&D: Antibiotic partners promote discovery.
    Bakken JS
    Nature; 2016 Sep; 537(7619):167. PubMed ID: 27604939
    [No Abstract]   [Full Text] [Related]  

  • 19. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial drug discovery.
    Fairlamb A; Cole S
    Future Microbiol; 2011 Jun; 6(6):601-2. PubMed ID: 21707305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.